- Home
- PROV vs RCEL Comparison
PROV vs RCEL Comparison
Compare PROV & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- RCEL
- Stock Information
- Founded
- PROV 1956
- RCEL N/A
- Country
- PROV United States
- RCEL United States
- Employees
- PROV N/A
- RCEL N/A
- Industry
- PROV Savings Institutions
- RCEL Medical/Dental Instruments
- Sector
- PROV Finance
- RCEL Health Care
- Exchange
- PROV Nasdaq
- RCEL Nasdaq
- Market Cap
- PROV 102.0M
- RCEL 113.7M
- IPO Year
- PROV 1996
- RCEL N/A
- Fundamental
- Price
- PROV $15.59
- RCEL $4.56
- Analyst Decision
- PROV Hold
- RCEL Strong Buy
- Analyst Count
- PROV 1
- RCEL 4
- Target Price
- PROV $16.50
- RCEL $13.75
- AVG Volume (30 Days)
- PROV 6.2K
- RCEL 282.4K
- Earning Date
- PROV 10-27-2025
- RCEL 11-06-2025
- Dividend Yield
- PROV 3.56%
- RCEL N/A
- EPS Growth
- PROV N/A
- RCEL N/A
- EPS
- PROV 0.93
- RCEL N/A
- Revenue
- PROV $39,666,000.00
- RCEL $74,884,000.00
- Revenue This Year
- PROV $7.74
- RCEL $28.23
- Revenue Next Year
- PROV $4.06
- RCEL $35.24
- P/E Ratio
- PROV $16.94
- RCEL N/A
- Revenue Growth
- PROV 1.90
- RCEL 38.32
- 52 Week Low
- PROV $12.98
- RCEL $3.60
- 52 Week High
- PROV $16.70
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- PROV 57.02
- RCEL 46.58
- Support Level
- PROV $15.35
- RCEL $4.12
- Resistance Level
- PROV $15.79
- RCEL $4.44
- Average True Range (ATR)
- PROV 0.20
- RCEL 0.25
- MACD
- PROV 0.02
- RCEL 0.03
- Stochastic Oscillator
- PROV 68.75
- RCEL 50.00
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.